Johnson & Johnson Acknowledges EP Market Competition, Expects China's VBP to Impact Market
Johnson & Johnson (JNJ) MedTech Chairman Tim Schmid acknowledged competitive pressure in the electrophysiology (EP) market, particularly in international and Asia-Pacific markets including China. He anticipates China's volume-based procurement (VBP) program will eventually affect the EP market, potentially later this year and into 2027, and plans to add one meaningful pulsed field ablation (PFA) catheter annually for the next three to five years.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
U.S. Treasury Sanctions Chinese-Language Cyber-Scam Hub Xinbi Guarantee
-
2
24/7 Wall St. Initiates Marvell Technology (MRVL) with Buy Rating, Sets Price Target at $281.53
-
3
MOL Chairman: Violent Yen Fluctuations Could Lead to Global Market "Chaos," Outlook for Strait of Hormuz Shipping Recovery Pessimistic
-
4
US-Iran Conflict Escalates: Iran Claims Attacks on US Vessels and Oil Tankers, Brent Crude Nears $100/Barrel
-
5
Chinese energy firms, including Sungrow and EVE Energy, warn policy volatility complicates long-term overseas expansion amid geopolitical risks
-
6
Iran eases currency rules to bypass US sanctions with crypto, per report
-
7
India's Manipur State Pledges to Complete Border Fencing with Myanmar by 2028
-
8
Dollar Nears Seven-Month Low as Yen Rallies; Traders Focus on US Buybacks and Inflation Data This Week
-
9
ING Chief Economist Blom Says One ECB Rate Hike 'Could Be Enough'
-
10
GINU Coin: A Multifaceted Analysis of GiveWell Inu, Green Shiba Inu, and Genie Inu's Trading Status
Markets Today
Recommended Reading



